Camela, E. et al. 2023. Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire. Dermatology Practical & Conceptual. 13, 3 (Jul. 2023), e2023177. DOI:https://doi.org/10.5826/dpc.1303a177.